Page 710 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 710

33


  VetBooks.ir


         Hematopoietic Tumors












          SECTION A: CANINE LYMPHOMA AND                       Genetic and Molecular Factors
          LYMPHOCYTIC LEUKEMIAS                                Advances in molecular cytogenetics (see  Chapter 1,  Section A),
                                                               including array-comparative genomic hybridization and chromosome
                                                               painting, have been and are currently being applied to investigations
         DAVID M. VAIL, MARIE PINKERTON, AND                   of chromosomal aberrations in dogs with lymphoma. 12–18  Publica-
         KAREN M. YOUNG                                        tion of the canine genome and commercial availability of canine gene
                                                               microarrays (GeneChip Canine Genome 2.0 Array, Affymetrix, Inc.)
         Lymphoma                                              have led to advances in our understanding of deregulations of gene
                                                                                          19
                                                               expression occurring in lymphoma.  Gains of canine chromosomes
         Lymphoma (malignant lymphoma or lymphosarcoma) comprises   13 and 31 and loss of chromosome 14 have been documented as the
                                                                                                           17
         a diverse group of neoplasms that have in common their origin   most common aberrations in a group of 25 cases analyzed.  Chro-
         from lymphocytes. The neoplasms usually arise in lymphoid tis-  mosomal aberrations have also been associated with prognosis in dogs
         sues such as lymph nodes (LNs), spleen, and bone marrow; how-  with lymphoma. A study of 61 dogs with lymphoma demonstrated a
         ever, they may arise in almost any tissue in the body. Although   prognostic advantage in dogs with trisomy of chromosome 13 (25%
         the annual incidence of lymphoma is difficult to predict in the   of the dogs studied), as evidenced by increase in duration of first remis-
         absence of a national canine tumor registry, it is clear that it rep-  sion and overall survival time (ST).  Germline and somatic genetic
                                                                                          20
         resents one of the most common neoplasms seen in the dog. The   mutations and altered oncogene/tumor suppressor gene expression,
         annual incidence has been estimated to range between 13 and    epigenetic changes (e.g., DNA hypomethylation), signal transduc-
         114 per 100,000 dogs at risk. The rates at specific ages are esti-  tion, and death-pathway alterations (e.g., Bcl-2 family) are common
         mated  to  be  1.5  per  100,000  for  dogs  less  than  1  year  of  age   in human lymphomas and have been reported in the dog as well (see
         and 84 per 100,000 for dogs 10 to 11 years old. 1–4  Lymphoma   Chapter 1, Section A, and Chapter 15, Section B). 21–25  These include
         comprises approximately 7% to 24% of all canine neoplasias and   N-ras, p53, Rb, p16 cyclin-dependent kinase, telomerase, and NF-κB
                                              5,6
         83% of all canine hematopoietic malignancies.  In a review of   among others. 22,26–31  Somatic mutations, as determined by exome
         the  Veterinary Medical Database Program (VMDP) at Purdue   sequencing, have shown much overlap in canine breeds with respect
         University from 1987 to 1997, the frequency of dogs presented   to B-cell lymphoma, specifically mutations in TRAF3-MAP3K14,
         with lymphoma to 20 veterinary institutions increased from   FBXW7, and POT1, but little overlap in somatic mutations among
         0.75% to 2.0% of total case load, and it appears the frequency   breeds with T-cell lymphoma.  In addition, differences in the preva-
                                                                                     21
         is continuing to increase. A similar trend is present in physician-  lence of immunophenotypic subtypes of lymphoma among different
                                                                                      32
         based oncology; non-Hodgkin’s lymphoma (NHL) represents 5%   breeds indicate heritable risks.  Telomerase activity (see Chapter 2)
         of all new cancer cases, the fifth leading cause of cancer death,   has also been documented in canine lymphoma tissues. 33–35  As
         and the second fastest growing cancer in terms of mortality in   somatic mutations are often implicated, it is not surprising that
         humans.  Middle-aged to older (median age of 6–9 years) dogs   alterations or deficiencies in DNA repair mechanisms would also
                7
         are primarily affected, although dogs with T-cell lymphoma tend   be implicated, as has been demonstrated in golden retrievers with
                     8
                                                                        36
         to be younger.  A decreased risk for lymphoma is reported for   lymphoma.  
         intact females.  Breeds reported to have a higher incidence include
                    9
         boxers, bullmastiffs, basset hounds, St. Bernards, Scottish terriers,   Infectious Factors
         Airedales, pitbulls, Briards, Irish setters, Rottweilers, and bulldogs;   The hypothesis that a retrovirus may be involved in the pathogen-
         breeds at lower risk include dachshunds and Pomeranians. 8,10,11    esis of canine lymphoma has not been confirmed. Epstein–Barr
         See Box 33.1.                                         virus, a gammaherpesvirus linked to some forms of lymphoma in
                                                               humans, has also been investigated in canine lymphoma; however,
         Etiology                                              there was no association between serologic or molecular detection
                                                               of gammaherpesvirus and development of lymphoma. 37,38
         The  etiology  of  canine  lymphoma  is likely  multifactorial  and   In humans, a direct association between Helicobacter sp. infec-
                                                                                                                39
         largely unknown; however, investigations are currently shedding   tions and development of gastric lymphoma has been made.
         significant light on the subject.                     Although this has not been definitively shown in dogs, there is


         688
   705   706   707   708   709   710   711   712   713   714   715